Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 6, 2009, Pages 693-699

  Milsom, Ian ^a,g   Axelsen, Susanne ^b   Kulseng Hansen, Sigurd ^c   Mattiasson, Anders ^d   Nilsson, Carl Gustaf ^e   Wickstrøm, Jannie ^f  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

^c Asker and Brum Hospital ^*  (Norway)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

^f Wickstrm Langkilde APS   (Denmark)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cost effectiveness; Nordic; Overactive bladder; Solifenacin; Urinary incontinence

Indexed keywords

PLACEBO; SOLIFENACIN; TOLTERODINE; BENZHYDRYL DERIVATIVE; CRESOL; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE; QUINUCLIDIN 3' YL 1 PHENYL 1,2,3,4 TETRAHYDROISOQUINOLINE 2 CARBOXYLATE MONOSUCCINATE; QUINUCLIDIN-3'-YL-1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE-2-CARBOXYLATE MONOSUCCINATE; QUINUCLIDINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DENMARK; FINLAND; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; NORWAY; OVERACTIVE BLADDER; PRIORITY JOURNAL; PRODUCTIVITY; RECOMMENDED DRUG DOSE; SCANDINAVIA; SUSTAINED DRUG RELEASE; SWEDEN; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; RANDOMIZED CONTROLLED TRIAL;

BENZHYDRYL COMPOUNDS; COST-BENEFIT ANALYSIS; CRESOLS; DECISION SUPPORT TECHNIQUES; FEMALE; FINLAND; HUMANS; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; QUINUCLIDINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCANDINAVIA; TETRAHYDROISOQUINOLINES; URINARY BLADDER, OVERACTIVE;

EID: 66149123002     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340902849738     Document Type: Article

References (38)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardization of terminology of lower urinary tract function: report from the Standardization Subcommittee of the International Continence Society. Neurol Urodyn. 2002;21:161-78.
2. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760-6.
3. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Hersc-horn S, et al. Population-based survey of urinary incontinence, overactive bladder and other lower urinary tract symptoms in five countries: Results of the EPIC study. Euro Urol. 2006;6:1306-15.
4. Reeves P, Lloyd A, Irwin DE, Milsom I, Kopp Z, Calvert N, et al. The current and future burden and cost of overactive bladder in five European countries. Eur Urol. 2006;50: 1050-7.
5. Hannestad YS, Rortveit G, Hunskaar S. Help-seeking and associated factors in female urinary incontinence. The Norwegian EPINCONT study. Epidemiology of incontinence in the county of Nord-Trondelag. Scand J Prim Health Care. 2002;20:102-7.
6. Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20-59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand. 1997;76:74-80.
7. Chapple CR, Martinez-Garcia R, Selvaggi L, Tooza-Hobson P, Warnack W, Drogendijk T, et al. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol. 2005;48:464-70.
8. Chapple CR, RechbergerT, Al-Shukris S, Meffan P, Everaert K, Huang M, et al. A randomized, double-blind placebo-and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int. 2004;93:303-10.
9. Cardozo L, Lisec M, Millard R, Van Vierssen Trip O, Kuzmin I, Drogendijk T, et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol. 2004;172:1919-24.
10. Haab F, Cardozo L, Chapple C, Ridder A. Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome. Eur Urol. 2005;47:376-84.
11. Kelleher C, Cardozo L, Chapple C, Haab F, Ridder A. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int. 2005;95:81-5.
12. Kobelt G. Economic considerations and outcome measurement in urge incontinence. Urology. 1997;50:100-7.
13. Szende A, Oppe M, Devlin N (eds). EQ-5D value sets. Inventory, comparative review and user guide. EuroqQol Group monographs, vol. 2, Springer, 2007.
14. Drummon M, Schulpher M, Torrance G, O'Brien B, Stoddart G (eds). Methods for economic evaluation of health care programs, 3rd edn. Oxford University Press, 2005.
15. Hu T, Wagner H, Bentkover J, Leblanc K, Zhou S, Hunt T Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology. 2004;63:461-5.
16. Southern Healthcare Region [Regionala priser och ersåttnin-ger för Södra sjukvårdsregionen]. Available online at: http://www.srvn.org/prislista.htm (accessed May 6, 2006).
17. South Eastern Region [Priser och ersättningar för sydöstra sjukvårdsregionen 2006]. Available online at: http:// www.lio.se/upload/16047/Prislista%202006.pdf (accessed May 6, 2006)
18. The Swedish Association of the Pharmaceutical Industry, LIF. [Läkemedelsfakta] Available online at: www.lfn.se (accessed May 18, 2006)
19. Region Skåne, incontinence portal, product catalogue. [Hjälpmedelinstitutet] Available online at: http://www. skane.se/upload/Webbplatser/MASkane/Portaler/Inkontinens/ dokument/Skanekatalog. pdf (accessed May 6, 2006).
20. Statistics Sweden. Available online at: http://www.scb.se/
21. Norwegian Medical Association. [Fastlegetariffen 2006-2007] Available online at: www.legeforeningen.no/assets/ Fastlegetariffen-2005.pdf (accessed August 23, 2006).
22. Norwegian Medical Association. [Normaltariffen 2006-2007] Available online at: http://www.legeforeningen.no/www. legeforeningen.no/assets/ Normaltariffen-2005.pdf (accessed August 23, 2006).
23. Norwegian Medicines Agency. 2006. [Søkebase for legemi-dler] Available online at: www.legemiddelverket.no/pris/ pia.htm (accessed August 23, 2006).
24. National Office for Social Insurance. 2006. [Sykepleieartikler] Available online at: http://www.trygdeetaten.no/sykdom/ helsepersonell/sykepleieartikler/ spa001ra-ink.pdf (accessed August 23, 2006).
25. Statistic Norway [Statististisk Sentralbyrå]. Tabell: 03837: Average salery per month [Gjennomsnittlig månedsfortje-neste for ansatte, heltidsekvivalenter, etter arbeidstid, nær-ingshovedområde og kjønn]. 2006. Available online at: www.ssb.no (accessed July 26, 2006).
26. Health Economist Timo Hujanen, STAKES, Centre for Health Economics Studies.
27. Sirkka Komppa from the Kuopio University Hospital, district Northern-Savo Kuopio.
28. Seppo Pakkala managing director of the HYKS-institute, Hospital district of Helsinki and Uusimaa.
29. The Finnish Medical Society Duodecim. Available online at: www.duodecim.fi/geneerinen/geneerinen.koti (accessed July 7, 2006).
30. Palvelu oy Metasäpolku. Available online at: www.metsa polku.com (accessed July 7, 2006).
31. Statistics Finland. Wages, salaries and labour costs. Available online at: www.stat.fi (accessed July 7, 2006).
32. Danish Medical Association. General practitioner. [Praktiser-ende lægers overenskomst (PLO) oktober 2005]. Available online at: http://www.dadlnet.dk/plo/open/index-plo.htm (accessed August 28, 2006).
33. Danish Medical Association. Gynecology & Obstetric [Over-enskomst specialpraktiserende læger, Gynækologi & Obste-trik, 2005]. Available online at: http://www.dadlnet.dk/ fas/open/lontakster/takstkort/ gyn&obs.htm#behandling (accessed August 28, 2006).
34. Danish Medical Association. Chirurgic. [Overenskomst spe- cialpraktiserende læger, kirurgi, 2005]. Available online at: http://www.dadlnet.dk/fas/open/lontakster/takstkort/kiru rgi.htm (accessed August 28, 2006).
35. Danish Medicine Agency. [Priser & medicintilskud] Available online at: www.medicinpriser.dk (accessed August 28, 2006).
36. Kirudan. [Katalog, inkontinens, bleer og bind] Available online at: https://e-handel.kirudan.dk/katalog (accessed August 28, 2006).
37. Statistics Denmark. [løn] Available online at: www.statistik-banken.dk (accessed August 28, 2006).
38. National Institute of Clinical Excellence. Guide to the methods of technology appraisal. NICE, April 2004. Available online at: www. nice.org.uk (accessed June 1, 2006).